Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)

NCT00788957 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

177

Enrollment

INDUSTRY

Sponsor class

Conditions

Colon Cancer
Colorectal Cancer
Gastrointestinal Cancer
Metastatic Colorectal Cancer
Rectal Cancer

Interventions

DRUG: Panitumumab
DRUG: Ganitumab
DRUG: Rilotumumab
DRUG: Placebo

Sponsor

NantBioScience, Inc.